printer-friendly version (PDF) - Reflex Sympathetic Dystrophy ...
printer-friendly version (PDF) - Reflex Sympathetic Dystrophy ...
printer-friendly version (PDF) - Reflex Sympathetic Dystrophy ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
FEATURE | COMPLEX REGIONAL PAIN SYNDROME<br />
Neuroimmunologic Approaches to<br />
Emerging and Potential Therapies<br />
for Complex Regional Pain<br />
Syndrome (CRPS)<br />
BY DONALD C. MANNING, MD, PhD<br />
Despite a great deal of progress in defining<br />
Complex Regional Pain Syndrome (CRPS),<br />
there is still controversy regarding the<br />
mechanisms involved.<br />
THEORIES HAVE INCLUDED INFLAMMATION, neuropathic mechanisms,<br />
ischemic injury and abnormal sympathetic nervous system<br />
function. To date there is no approved treatment for<br />
CRPS, and therapies for neuropathic or inflammatory pain<br />
have given disappointing results, affording many patients only<br />
partial relief at best (1). Therefore, it is time for a reevaluation<br />
of CRPS mechanisms to enable new therapeutic opportunities.<br />
The high female predominance (75%) and the combination of<br />
inflammatory and neuropathic pain components could be consistent<br />
with an autoimmune mechanism. Targeting therapies<br />
toward immune activation involving cytokines, glia, or the<br />
infiltration of immune cells is a new approach for pain therapy,<br />
although it has already been employed with some success in<br />
oncology and rheumatology.<br />
Neuroimmune activation involves a bidirectional stimulation<br />
of neurons and immune cells in response to trauma or<br />
inflammation (2). Immune cells release inflammatory [e.g.,<br />
cytokines tumor necrosis factor (TNF), interleukin (IL)-1<br />
and IL-6] and anti-inflammatory (e.g., cytokine IL-10)<br />
molecules and they, in turn, are modulated by neurotransmitters,<br />
especially the sympathetic nervous system transmitter norepinephrine<br />
(3,4). Cytokines are polypeptides that can act<br />
locally, within tissues, or at a distance similar to hormones.<br />
They regulate replication, development and activation of cells<br />
in the immune, nervous and hematopoetic systems. The biology<br />
of the cytokines is complicated in that different cells can<br />
produce the same cytokine that can in turn have different<br />
effects or different cytokines can have similar effects or antagonize<br />
each other depending upon the local environment.<br />
Cytokines as Chronic Pain Mediators<br />
TNF, IL-1 AND IL-6 are the cytokines with the best-documented<br />
pathological roles in neuropathic pain. In healthy animals,<br />
the administration of IL-1 or TNF alone can produce<br />
symptoms of neuropathic pain. Spinal neuron activation by<br />
these cytokines can produce long-term alterations in neuronal<br />
excitability. Activation of non-neuronal glial cells with extensive<br />
interconnections within the spinal cord could account for central<br />
cytokine release (5) as well as the spread of excitation<br />
beyond traditional neuroanatomical boundaries and reactivation<br />
of the pain system after new injuries (6). Infusion of IL-1 or<br />
TNF for adjuvant cancer chemotherapy has been associated<br />
with an incidence of nearly 50% of pain syndromes or complaints<br />
of pain and tenderness at the injection site (7-9).<br />
Whereas TNF and IL-1 play important roles in the<br />
T H E PA I N P R A C T I T I O N E R | V O L U M E 16 , N U M B E R 1 | 59